PATIENT-REPORTED QUALITY OF LIFE IN PATIENTS WITH BASELINE OBJECTIVE SIGNS OF INFLAMMATION AND ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS TREATED WITH GOLIMUMAB: RESULTS OF THE OPEN-LABEL EXTENSION OF A RANDOMIZED, DOUBLE-BLIND STUDY